Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients. Feb 12, 2013 | Uncategorized
Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform. Feb 12, 2012 | Uncategorized
A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors. Feb 12, 2012 | Uncategorized
Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine. Feb 12, 2011 | Uncategorized
Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA. Feb 12, 2010 | Uncategorized
